Study protocol of a phase II clinical trial evaluating the efficacy of neoadjuvant intraperitoneal and systemic albumin-bound paclitaxel combined with camrelizumab and S-1 in the treatment of patients with exfoliative cell-positive gastric cancer

Study protocol of a phase II clinical trial evaluating the efficacy of neoadjuvant intraperitoneal and systemic albumin-bound paclitaxel combined with camrelizumab and S-1 in the treatment of patients with exfoliative cell-positive gastric cancer

BackgroundCurrently, gastric cancer with positive lavage cytology without gross peritoneal dissemination (GC-CY1) is a special type of metastatic form with poor prognosis. Consensus guidelines on treatment strategies for patients with GC-CY1 have not been established. This study involves a single-ar...

Full description

Bibliographic Details
Main Authors: Jingxia Lv, Jiaxiang Wu, Haotian Wu, Ping’an Ding, Honghai Guo, Peigang Yang, Yuan Tian, Yang Liu, Qun Zhao
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-09-01
Series:Frontiers in Oncology
Subjects:
neoadjuvant intraperitoneal and systemic
conversion treatment
gastric cancer
positive lavage cytology
camrelizumab
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1201928/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1201928/full

Similar Items